Perceptions and barriers of adverse drug reaction reporting within inpatient state psychiatric facilities
- PMID: 36071738
- PMCID: PMC9405632
- DOI: 10.9740/mhc.2022.08.247
Perceptions and barriers of adverse drug reaction reporting within inpatient state psychiatric facilities
Abstract
Introduction: Adverse drug reactions (ADRs) are a leading cause of morbidity and mortality for hospitalized patients. Health care organizations track ADRs to reduce patient mortality, reduce hospital readmissions, decrease costs, and improve patient care. Differing definitions of ADRs cause confusion among providers, leading to hesitation with ADR reporting. The objective of this study was to understand health care professionals' perspectives of ADR reporting within inpatient state psychiatric facilities.
Methods: A survey was sent to 143 health care professionals throughout 25 inpatient state psychiatric facilities within 1 state. The survey assessed the definition of an ADR, confidence in reporting, barriers to reporting, the role of reporting, who should report and review ADRs, and strategies for process improvement.
Results: The survey had a 75.5% response rate with 108 respondents. Most respondents could identify the definition of an ADR, were moderately confident in reporting ADRs, and understood the importance of ADR reporting. Barriers to ADR reporting included the reaction not being serious, a lack of information about the ADR, or not enough clarity on how to report an ADR. Fear of retaliation was an additional barrier to ADR reporting. Training and direction on ADR reporting, education on real versus perceived consequences, a designated point person to aid in reporting, and better access to reporting technology were suggested improvements for ADR reporting.
Discussion: From this survey, it is evident that respondents believe improved education and training, improved communication regarding reporting consequences, and consensus on the definition of an ADR would encourage reporting.
Keywords: adverse drug reactions; fear of retaliation; reporting barriers.
© 2022 AAPP. The Mental Health Clinician is a publication of the American Association of Psychiatric Pharmacists.
Similar articles
-
A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain.Drug Saf. 2000 Aug;23(2):165-72. doi: 10.2165/00002018-200023020-00006. Drug Saf. 2000. PMID: 10945377
-
Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom.Pharm Pract (Granada). 2017 Jul-Sep;15(3):931. doi: 10.18549/PharmPract.2017.03.931. Epub 2017 Aug 8. Pharm Pract (Granada). 2017. PMID: 28943977 Free PMC article.
-
Patient Reporting of Adverse Drug Reactions (ADRs): Survey of Public Awareness and Predictors of Confidence to Report.Ther Innov Regul Sci. 2018 Nov;52(6):757-763. doi: 10.1177/2168479017745025. Epub 2018 Mar 1. Ther Innov Regul Sci. 2018. PMID: 29714567
-
Current Scenario and Future Prospects of Adverse Drug Reactions (ADRs) Monitoring and Reporting Mechanisms in the Rural Areas of India.Curr Drug Saf. 2024;19(2):172-190. doi: 10.2174/1574886318666230428144120. Curr Drug Saf. 2024. PMID: 37132145 Review.
-
Nurses' Knowledge, Attitudes, and Practice in Relation to Pharmacovigilance and Adverse Drug Reaction Reporting: A Systematic Review.Biomed Res Int. 2021 Apr 9;2021:6630404. doi: 10.1155/2021/6630404. eCollection 2021. Biomed Res Int. 2021. PMID: 33937402 Free PMC article.
Cited by
-
Pharmacovigilance and Adverse Drug Reactions Reporting: Healthcare Providers' Experiences from Southern Highland Tanzania.Adv Pharmacol Pharm Sci. 2023 Oct 16;2023:5537592. doi: 10.1155/2023/5537592. eCollection 2023. Adv Pharmacol Pharm Sci. 2023. PMID: 37876921 Free PMC article.
-
Integrating a Pharmacovigilance and Response Unit Team for a Better Adverse Drug Reaction Reporting and Management: Insights from a Prospective Cross-Sectional Study.Turk J Pharm Sci. 2025 May 14;22(2):83-90. doi: 10.4274/tjps.galenos.2025.44902. Turk J Pharm Sci. 2025. PMID: 40366197 Free PMC article.
References
-
- Centers for Disease Control and Prevention [Internet] Adverse drug events in adults; 2017 [updated. cited 2022 Jan 13] 2017. Oct 11, Available from: https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html.
-
- Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(5):73. 10.4103/0976-500X.120957 PubMed PMID: 24347988 PubMed Central PMCID: PMC3853675. - DOI - PMC - PubMed
-
- Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439. 10.1371/journal.pone.0004439 PubMed PMID: 19209224 PubMed Central PMCID: PMC2635959. - DOI - PMC - PubMed
-
- FDA. Preventable adverse drug reactions a focus on drug interactions. 2022. [cited. Jan 13]. Available at: https://www.fda.gov/drugs/drug-interactions-labeling/preventable-adverse....
-
- Lee LM, Carias DC, Gosser R, Hannah A, Stephens S, Templeman W. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm. 2022;79:e83–9. 10.1093/ajhp/zxab324 PubMed PMID: 34480176. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Research Materials